S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Accounts Receivables Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Accounts Receivables
NT$368.8m
CAGR 3-Years
39%
CAGR 5-Years
-4%
CAGR 10-Years
7%
Y
YungShin Global Holding Corp
TWSE:3705
Accounts Receivables
NT$1.5B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Accounts Receivables
NT$1.2B
CAGR 3-Years
19%
CAGR 5-Years
8%
CAGR 10-Years
4%
ScinoPharm Taiwan Ltd
TWSE:1789
Accounts Receivables
NT$478.6m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Accounts Receivables
NT$6.1B
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
20%
Standard Chem & Pharm Co Ltd
TWSE:1720
Accounts Receivables
NT$1.1B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%

See Also

What is SCI Pharmtech Inc's Accounts Receivables?
Accounts Receivables
368.8m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Accounts Receivables amounts to 368.8m TWD.

What is SCI Pharmtech Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
7%

Over the last year, the Accounts Receivables growth was 29%. The average annual Accounts Receivables growth rates for SCI Pharmtech Inc have been 39% over the past three years , -4% over the past five years , and 7% over the past ten years .

Back to Top